Navigation Links
Past gains in reducing risk of heart disease have flattened, women especially affected

NEW ORLEANS - The positive U.S. health trend documented over the past 30 years of reduction in risk for heart disease is not as strong as is widely perceived - and, in fact, the trend has flattened, according to a new analysis of national data by Mayo Clinic.

This suggests that the public health challenge of curbing heart disease may be greater than is commonly thought, says Francisco Lopez-Jimenez, M.D., cardiologist and lead researcher.

"This study may surprise people because the data show that the risk of heart disease is not going down as we expected," he says. "The estimated risk in our nation was coming down nicely in the 1980s. Then around 2000 it began changing - the trend lines flattened. While we had done a nice job with lowering cholesterol, blood pressure and stopping smoking, over time the improvement in these risk factors slowed and others like diabetes and obesity emerged, threatening to undo the early progress we made in reducing risk of heart disease. Most of the gains in reducing heart disease risk have been offset by the increased prevalence of diabetes and obesity."

Dr. Lopez-Jimenez presents the findings today at the American Heart Association's Scientific Sessions 2008 in New Orleans.


The study is the first to suggest that not as much progress against heart disease is being made in recent years, despite the efforts by many organizations to promote healthy lifestyles, and the wide availability and lower price of many cholesterol and blood pressure-lowering drugs. "This is highly relevant to public health because most people think the risk of heart disease is going down steadily and has for the past 30 to 40 years - but our data show something different," Dr. Lopez-Jimenez says. "The fact is that despite all the wonderful things we've done - all the changes in fat consumption, the promotion of exercise, the quitting smoking, treatment of high cholesterol and blood pressure - it doesn't appear to be enough; the risk reduction we did achieve early on in the 1980s has gone flat, and we need to change that."

The researchers compared national heart disease risk factor data from three time periods to track change over time in risk reduction. The early period documented changes in risk between 1976 and 1980 and a midpoint of 1988 to 1994. The last period documented changes in risk from the midpoint to 1999 - 2004. Comparing changes from the early stage to the midpoint documented a decline in the overall risk to develop heart disease; but comparing change from the midpoint to the late period showed the trend flattening.

"No one has ever compared national data this way, which is why we are the first to detect this worrisome flattening of the trend in risk factor reduction," Dr. Lopez-Jimenez says.

Key Findings

The data show that, in the U.S., the average age-adjusted 10-year risk of heart disease:

  • Decreased from 10 percent to 7.9 percent between the early period and the midpoint - a strong showing of progress in controlling risk factors during the 1980s.
  • Decreased only minimally in the interval from the midpoint to the last period, from 7.9 percent to 7.4 percent. This documents the flattening of the healthy trend.

For women, in particular, the age-adjusted risk declined from the early period to the midpoint, but stayed flat from the midpoint to the late period, Dr. Lopez-Jimenez says. Similarly, when age groups were compared, the average predicted risk for those ages 30 to 49 stayed flat from the midpoint to the late period compared to people age 50 and above, he says.


Contact: Traci Klein
Mayo Clinic

Related medicine news :

1. Two Antioxidant Vitamins Dont Protect Against Heart Disease
2. AMA to Support Laws Against Text Messaging While Driving
3. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
4. MTVs Staying Alive Marks Ten Years of Empowering Young People in Their Fight against HIV and AIDS
5. Aspirin Doesnt Guard Diabetics Against Heart Disease
6. Activity Against MRSA is the Most Important Attribute Influencing Physicians Antibiotic Selection for the Treatment of Skin and Skin Structure Infections
7. Preeclampsia Might Protect Against Testicular Cancer
8. Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Readers Digest for Exemplifying the Fight Against Breast Cancer
9. Natural Hormone Balance: Gaining Ground in the Fight Against Breast Cancer
10. National Breast Cancer Coalition Survey Reveals That Lack of Commitment and Funding Impede the Fight Against Breast Cancer
11. Rowenta, Iron Manufacturer, Pits Marines, Quilters, Mothers and Daughters Against One Another to Help Iron Out Breast Cancer
Post Your Comments:
(Date:12/1/2015)... PA (PRWEB) , ... December 01, 2015 , ... ... imaging facilities, radiographic technicians must mark the film for accurate interpretation by the ... track of. Fortunately, an inventor from Sacramento, Calif., has found a way to ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , ... membership and leadership since 2008. Gary Bruce, President of PartnerTech North America, currently ... spent a significant amount of time in Sweden since joining PartnerTech based in ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani ... support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center ...
(Date:11/30/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... honors Christina Colon as a 2015-2016 inductee into its VIP Woman ... in pharmacy. NAPW is the nation’s leading networking organization exclusively for professional women, ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015  Lexicon Pharmaceuticals, Inc. ... top-line data from its TELECAST Phase 3 ... treating carcinoid syndrome in cancer patients with ... benefit observed in its pivotal TELESTAR study.  ... companion to TELESTAR primarily to provide additional ...
(Date:12/1/2015)... , Dec. 1, 2015  ImmunoCellular Therapeutics, ... Andrew Gengos , President and Chief ... on December 3, 2015. Mr. Gengos plans ... registrational program in patients with newly diagnosed ... TIME:    12:15p.m. ET/9:15a.m. PT LINK: ...
(Date:12/1/2015)... and UPPSALA, Sweden , December ... been selected by the International Breast Cancer Study Group (IBCSG, ... (BIG, Brussels ) to be part of ... palbociclib, a promising new cancer drug.  --> ... women with advanced breast cancer being treated with anti-hormonal therapy ...
Breaking Medicine Technology: